Sio Gene Therapies Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sio Gene Therapies Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q4 2022.
  • Sio Gene Therapies Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $0 -$2.61M -100% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $7K -$1.05M -99.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.27M +$1.16M +106% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.44M +$1.29M +112% Mar 31, 2022 10-Q 2023-02-14
Q4 2021 $2.61M +$1.27M +94% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $1.05M +$389K +58.7% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.1M -$2K -0.18% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.15M -$380K -24.8% Mar 31, 2021 10-K 2022-06-14
Q4 2020 $1.35M -$599K -30.8% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $663K -$1.57M -70.4% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $1.11M -$1.56M -58.5% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $1.53M Mar 31, 2020 10-K 2021-06-09
Q4 2019 $1.95M Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $2.24M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $2.66M Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.